Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma

Thyroid

Volumn 22, Issue 7, 2012, Pages 725-729

  Kim, Bum Soo ^a   Kim, Seong Jang ^a   Kim, In Joo ^a   Pak, Kyounjune ^a   Kim, Keunyoung ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX RATIO; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

ADULT; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84863453264     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0031     Document Type: Article

References (16)

1. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N. Engl. J. Med 338:297-306.
2. Zuijdwijk MD, Vogel WV, Corstens FH, Oyen WJ 2008 Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma. Nucl Med Commun 29:636-641.
3. Razfar A, Branstetter BF 4th, Chistopoulos A, Lebeau SO, Hodak SP, Heron DE, Escott EJ, Ferris RL 2010 Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma. Arch Otolaryngol Head Neck Surg 136:120-125.
4. Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY 1999 Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 40:993-994.
5. Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W 1996 Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468-1472.
6. American Joint Committee on Cancer Staging 2002 Manual for Staging of Cancer, 6th ed. J.B. Lippincott, Philadelphia, PA.
7. Yun M, Noh TW, Cho A, Choi YJ, Hong SW, Park CS, Lee JD, Kim CK 2010 Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: A potential new risk factor. J Clin Endocrinol Metab 95:3182-3188.
8. Choi JW, Yoon YH, Yoon YH, Kim SM, Koo BS 2011 Characteristics of primary papillary thyroid carcinoma with falsenegative findings on initial (18)F-FDG PET/CT. Ann Surg Oncol 18:1306-1311.
9. Jeong HS, Chung M, Baek CH, Ko YH, Choi JY, Son YI 2006 Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas? Laryngoscope 116: 2133-2137.
10. Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. 2007 US Features of thyroid malignancy: Pearls and pitfalls. Radiographics 27:847-860.
11. Morita S, Mizoguchi K, Suzuki M, Iizuka K 2010 The accuracy of (18)[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma. Word J Surg 34:2564-2569.
12. Srinivas SM, Dhurairaj T, Basu S, Bural G, Surti S, Alavi A 2009A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med 23:341-348.
13. Rousset OG, Ma Y, Evans AC 1998 Correction for partial volume effects in PET: Principle and validation. J Nucl Med 39:904-911.
14. Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK 2008 Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: Assigning a probability of malignancy may be preferable to binary readings. Ann Nucl Med 22:165-170.
15. Bogsrud TV, Hay ID, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Björo T, Lowe VJ 2011 Prognostic value of 18F-fluorodeoxyglucosepositron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies. Nucl Med Commun 32:245-251.
16. Khan N, Oriuchi N, Higuchi T, Zhang H, Endo K 2003 PET in the follow-up of differentiated thyroid cancer. Br J Radiol 76:690-695.